APO Research
Talk to an analyst

APO RESEARCH · REPORT

Traditional Chinese Herbal Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Traditional Chinese Herbal Medicine Market Outlook and Growth Opportunities 2026

30 December 2025211 pages

Choose your research edition.

Industry ResearchTraditional Chinese Herbal Medicine Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Traditional Chinese Herbal Medicine Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Traditional Chinese Herbal Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Traditional Chinese Herbal Medicine Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Traditional Chinese Herbal Medicine Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Traditional Chinese Herbal Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Traditional Chinese Herbal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Traditional Chinese Herbal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Traditional Chinese Herbal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Traditional Chinese Herbal Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Traditional Chinese Herbal Medicine market include Yunnan Baiyao, Yiling Pharmaceutical, Zhejiang Conba Pharmaceutical, Qingfeng Pharmaceutical Group, Harbin Pharmaceutical Group, Guangzhou Pharmaceutical, Wuzhou Pharmaceutical, ZBD Pharmaceutical and Yusheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Traditional Chinese Herbal Medicine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Traditional Chinese Herbal Medicine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Traditional Chinese Herbal Medicine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Traditional Chinese Herbal Medicine market.

Traditional Chinese Herbal Medicine Segment by Company

Yunnan Baiyao

Yiling Pharmaceutical

Zhejiang Conba Pharmaceutical

Qingfeng Pharmaceutical Group

Harbin Pharmaceutical Group

Guangzhou Pharmaceutical

Wuzhou Pharmaceutical

ZBD Pharmaceutical

Yusheng Pharmaceutical

Tongrentang

TASLY

Shineway Pharmaceutical

Livzon

Jumpcan

Green Valley Pharma

Gerun Pharmaceutical

Fusen Pharmaceutical

CR SANJIU

China TCM

Chase Sun Pharmaceutical

Buchang Pharmaceutical

Traditional Chinese Herbal Medicine Segment by Type

Chinese Herbal Medicine

Chinese Herbal Extract

Others

Traditional Chinese Herbal Medicine Segment by Application

Adult

Children

Traditional Chinese Herbal Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Traditional Chinese Herbal Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Traditional Chinese Herbal Medicine key companies, revenue, market share, and recent developments.

3. To split the Traditional Chinese Herbal Medicine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Traditional Chinese Herbal Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Traditional Chinese Herbal Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Traditional Chinese Herbal Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Traditional Chinese Herbal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Traditional Chinese Herbal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Traditional Chinese Herbal Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Traditional Chinese Herbal Medicine industry.

Chapter 3: Detailed analysis of Traditional Chinese Herbal Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Traditional Chinese Herbal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Traditional Chinese Herbal Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Traditional Chinese Herbal Medicine Industry Trends Table 2. Traditional Chinese Herbal Medicine Industry Drivers Table 3. Traditional Chinese Herbal Medicine Industry Opportunities and Challenges Table 4. Traditional Chinese Herbal Medicine Industry Restraints Table 5. Global Traditional Chinese Herbal Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Traditional Chinese Herbal Medicine Revenue Share by Company (2021-2026) Table 7. Global Traditional Chinese Herbal Medicine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Traditional Chinese Herbal Medicine Key Company Manufacturing Base & Headquarters Table 9. Global Traditional Chinese Herbal Medicine Company, Product Type & Application Table 10. Global Traditional Chinese Herbal Medicine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Traditional Chinese Herbal Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chinese Herbal Medicine Table 15. Significant Companies of Chinese Herbal Extract Table 16. Significant Companies of Others Table 17. Global Traditional Chinese Herbal Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Traditional Chinese Herbal Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Traditional Chinese Herbal Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Traditional Chinese Herbal Medicine Sales Value Share by Type (2021-2026) Table 21. Global Traditional Chinese Herbal Medicine Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Adult Table 23. Significant Companies of Children Table 24. Global Traditional Chinese Herbal Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Traditional Chinese Herbal Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Traditional Chinese Herbal Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Traditional Chinese Herbal Medicine Sales Value Share by Application (2021-2026) Table 28. Global Traditional Chinese Herbal Medicine Sales Value Share by Application (2027-2032) Table 29. Global Traditional Chinese Herbal Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Traditional Chinese Herbal Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Traditional Chinese Herbal Medicine Sales Value Share by Region (2021-2026) Table 32. Global Traditional Chinese Herbal Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Traditional Chinese Herbal Medicine Sales Value Share by Region (2027-2032) Table 34. Global Traditional Chinese Herbal Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Traditional Chinese Herbal Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Traditional Chinese Herbal Medicine Sales Value Market Share by Country (2021-2026) Table 37. Global Traditional Chinese Herbal Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Traditional Chinese Herbal Medicine Sales Value Market Share by Country (2027-2032) Table 39. Yunnan Baiyao Company Information Table 40. Yunnan Baiyao Business Overview Table 41. Yunnan Baiyao Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Yunnan Baiyao Traditional Chinese Herbal Medicine Product Portfolio Table 43. Yunnan Baiyao Recent Development Table 44. Yiling Pharmaceutical Company Information Table 45. Yiling Pharmaceutical Business Overview Table 46. Yiling Pharmaceutical Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Yiling Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 48. Yiling Pharmaceutical Recent Development Table 49. Zhejiang Conba Pharmaceutical Company Information Table 50. Zhejiang Conba Pharmaceutical Business Overview Table 51. Zhejiang Conba Pharmaceutical Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Zhejiang Conba Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 53. Zhejiang Conba Pharmaceutical Recent Development Table 54. Qingfeng Pharmaceutical Group Company Information Table 55. Qingfeng Pharmaceutical Group Business Overview Table 56. Qingfeng Pharmaceutical Group Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Qingfeng Pharmaceutical Group Traditional Chinese Herbal Medicine Product Portfolio Table 58. Qingfeng Pharmaceutical Group Recent Development Table 59. Harbin Pharmaceutical Group Company Information Table 60. Harbin Pharmaceutical Group Business Overview Table 61. Harbin Pharmaceutical Group Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Harbin Pharmaceutical Group Traditional Chinese Herbal Medicine Product Portfolio Table 63. Harbin Pharmaceutical Group Recent Development Table 64. Guangzhou Pharmaceutical Company Information Table 65. Guangzhou Pharmaceutical Business Overview Table 66. Guangzhou Pharmaceutical Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Guangzhou Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 68. Guangzhou Pharmaceutical Recent Development Table 69. Wuzhou Pharmaceutical Company Information Table 70. Wuzhou Pharmaceutical Business Overview Table 71. Wuzhou Pharmaceutical Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Wuzhou Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 73. Wuzhou Pharmaceutical Recent Development Table 74. ZBD Pharmaceutical Company Information Table 75. ZBD Pharmaceutical Business Overview Table 76. ZBD Pharmaceutical Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ZBD Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 78. ZBD Pharmaceutical Recent Development Table 79. Yusheng Pharmaceutical Company Information Table 80. Yusheng Pharmaceutical Business Overview Table 81. Yusheng Pharmaceutical Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Yusheng Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 83. Yusheng Pharmaceutical Recent Development Table 84. Tongrentang Company Information Table 85. Tongrentang Business Overview Table 86. Tongrentang Traditional Chinese Herbal Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Tongrentang Traditional Chinese Herbal Medicine Product Portfolio Table 88. Tongrentang Recent Development Table 89. TASLY Company Information Table 90. TASLY Business Overview Table 91. TASLY Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. TASLY Traditional Chinese Herbal Medicine Product Portfolio Table 93. TASLY Recent Development Table 94. Shineway Pharmaceutical Company Information Table 95. Shineway Pharmaceutical Business Overview Table 96. Shineway Pharmaceutical Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shineway Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 98. Shineway Pharmaceutical Recent Development Table 99. Livzon Company Information Table 100. Livzon Business Overview Table 101. Livzon Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Livzon Traditional Chinese Herbal Medicine Product Portfolio Table 103. Livzon Recent Development Table 104. Jumpcan Company Information Table 105. Jumpcan Business Overview Table 106. Jumpcan Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jumpcan Traditional Chinese Herbal Medicine Product Portfolio Table 108. Jumpcan Recent Development Table 109. Green Valley Pharma Company Information Table 110. Green Valley Pharma Business Overview Table 111. Green Valley Pharma Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Green Valley Pharma Traditional Chinese Herbal Medicine Product Portfolio Table 113. Green Valley Pharma Recent Development Table 114. Gerun Pharmaceutical Company Information Table 115. Gerun Pharmaceutical Business Overview Table 116. Gerun Pharmaceutical Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Gerun Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 118. Gerun Pharmaceutical Recent Development Table 119. Fusen Pharmaceutical Company Information Table 120. Fusen Pharmaceutical Business Overview Table 121. Fusen Pharmaceutical Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Fusen Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 123. Fusen Pharmaceutical Recent Development Table 124. CR SANJIU Company Information Table 125. CR SANJIU Business Overview Table 126. CR SANJIU Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. CR SANJIU Traditional Chinese Herbal Medicine Product Portfolio Table 128. CR SANJIU Recent Development Table 129. China TCM Company Information Table 130. China TCM Business Overview Table 131. China TCM Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. China TCM Traditional Chinese Herbal Medicine Product Portfolio Table 133. China TCM Recent Development Table 134. Chase Sun Pharmaceutical Company Information Table 135. Chase Sun Pharmaceutical Business Overview Table 136. Chase Sun Pharmaceutical Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Chase Sun Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 138. Chase Sun Pharmaceutical Recent Development Table 139. Buchang Pharmaceutical Company Information Table 140. Buchang Pharmaceutical Business Overview Table 141. Buchang Pharmaceutical Traditional Chinese Herbal Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Buchang Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio Table 143. Buchang Pharmaceutical Recent Development Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Traditional Chinese Herbal Medicine Product Image Figure 2. Global Traditional Chinese Herbal Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Traditional Chinese Herbal Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Traditional Chinese Herbal Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chinese Herbal Medicine Image Figure 8. Chinese Herbal Extract Image Figure 9. Others Image Figure 10. Global Traditional Chinese Herbal Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Traditional Chinese Herbal Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Traditional Chinese Herbal Medicine Sales Value Share by Type (2021-2032) Figure 13. Adult Image Figure 14. Children Image Figure 15. Global Traditional Chinese Herbal Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Traditional Chinese Herbal Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Traditional Chinese Herbal Medicine Sales Value Share by Application (2021-2032) Figure 18. Global Traditional Chinese Herbal Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Traditional Chinese Herbal Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Traditional Chinese Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 21. North America Traditional Chinese Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Traditional Chinese Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Traditional Chinese Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Traditional Chinese Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Traditional Chinese Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Traditional Chinese Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 27. South America Traditional Chinese Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Traditional Chinese Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Traditional Chinese Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Chinese Herbal Medicine
  • Chinese Herbal Extract
  • Others
Applications
  • Adult
  • Children
Companies covered
  • Yunnan Baiyao
  • Yiling Pharmaceutical
  • Zhejiang Conba Pharmaceutical
  • Qingfeng Pharmaceutical Group
  • Harbin Pharmaceutical Group
  • Guangzhou Pharmaceutical
  • Wuzhou Pharmaceutical
  • ZBD Pharmaceutical
  • Yusheng Pharmaceutical
  • Tongrentang
  • TASLY
  • Shineway Pharmaceutical
  • Livzon
  • Jumpcan
  • Green Valley Pharma
  • Gerun Pharmaceutical
  • Fusen Pharmaceutical
  • CR SANJIU
  • China TCM
  • Chase Sun Pharmaceutical
  • Buchang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Traditional Chinese Herbal Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Traditional Chinese Herbal Medicine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Traditional Chinese Herbal Medicine Market Dynamics
  1. 2.1 Traditional Chinese Herbal Medicine Industry Trends
  2. 2.2 Traditional Chinese Herbal Medicine Industry Drivers
  3. 2.3 Traditional Chinese Herbal Medicine Industry Opportunities and Challenges
  4. 2.4 Traditional Chinese Herbal Medicine Industry Restraints
3 Traditional Chinese Herbal Medicine Market by Company
  1. 3.1 Global Traditional Chinese Herbal Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Traditional Chinese Herbal Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Traditional Chinese Herbal Medicine Company Ranking (2024-2026)
  4. 3.4 Global Traditional Chinese Herbal Medicine Company Manufacturing Base and Headquarters
  5. 3.5 Global Traditional Chinese Herbal Medicine Company Product Type and Application
  6. 3.6 Global Traditional Chinese Herbal Medicine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Traditional Chinese Herbal Medicine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Traditional Chinese Herbal Medicine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Traditional Chinese Herbal Medicine Market by Type
  1. 4.1 Traditional Chinese Herbal Medicine Type Introduction
  2. 4.1.1 Chinese Herbal Medicine
  3. 4.1.2 Chinese Herbal Extract
  4. 4.1.3 Others
  5. 4.2 Global Traditional Chinese Herbal Medicine Sales Value by Type
  6. 4.2.1 Global Traditional Chinese Herbal Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Traditional Chinese Herbal Medicine Sales Value by Type (2021-2032)
  8. 4.2.3 Global Traditional Chinese Herbal Medicine Sales Value Share by Type (2021-2032)
5 Traditional Chinese Herbal Medicine Market by Application
  1. 5.1 Traditional Chinese Herbal Medicine Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Traditional Chinese Herbal Medicine Sales Value by Application
  5. 5.2.1 Global Traditional Chinese Herbal Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Traditional Chinese Herbal Medicine Sales Value by Application (2021-2032)
  7. 5.2.3 Global Traditional Chinese Herbal Medicine Sales Value Share by Application (2021-2032)
6 Traditional Chinese Herbal Medicine Regional Value Analysis
  1. 6.1 Global Traditional Chinese Herbal Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Traditional Chinese Herbal Medicine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Traditional Chinese Herbal Medicine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Traditional Chinese Herbal Medicine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Traditional Chinese Herbal Medicine Sales Value (2021-2032)
  7. 6.3.2 North America Traditional Chinese Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Traditional Chinese Herbal Medicine Sales Value (2021-2032)
  10. 6.4.2 Europe Traditional Chinese Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Traditional Chinese Herbal Medicine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Traditional Chinese Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Traditional Chinese Herbal Medicine Sales Value (2021-2032)
  16. 6.6.2 South America Traditional Chinese Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Traditional Chinese Herbal Medicine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Traditional Chinese Herbal Medicine Sales Value Share by Country, 2025 VS 2032
7 Traditional Chinese Herbal Medicine Country-level Value Analysis
  1. 7.1 Global Traditional Chinese Herbal Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Traditional Chinese Herbal Medicine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Traditional Chinese Herbal Medicine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Traditional Chinese Herbal Medicine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Traditional Chinese Herbal Medicine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Traditional Chinese Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Traditional Chinese Herbal Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunnan Baiyao
  2. 8.1.1 Yunnan Baiyao Company Information
  3. 8.1.2 Yunnan Baiyao Business Overview
  4. 8.1.3 Yunnan Baiyao Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yunnan Baiyao Traditional Chinese Herbal Medicine Product Portfolio
  6. 8.1.5 Yunnan Baiyao Recent Developments
  7. 8.2 Yiling Pharmaceutical
  8. 8.2.1 Yiling Pharmaceutical Company Information
  9. 8.2.2 Yiling Pharmaceutical Business Overview
  10. 8.2.3 Yiling Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yiling Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  12. 8.2.5 Yiling Pharmaceutical Recent Developments
  13. 8.3 Zhejiang Conba Pharmaceutical
  14. 8.3.1 Zhejiang Conba Pharmaceutical Company Information
  15. 8.3.2 Zhejiang Conba Pharmaceutical Business Overview
  16. 8.3.3 Zhejiang Conba Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang Conba Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  18. 8.3.5 Zhejiang Conba Pharmaceutical Recent Developments
  19. 8.4 Qingfeng Pharmaceutical Group
  20. 8.4.1 Qingfeng Pharmaceutical Group Company Information
  21. 8.4.2 Qingfeng Pharmaceutical Group Business Overview
  22. 8.4.3 Qingfeng Pharmaceutical Group Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Qingfeng Pharmaceutical Group Traditional Chinese Herbal Medicine Product Portfolio
  24. 8.4.5 Qingfeng Pharmaceutical Group Recent Developments
  25. 8.5 Harbin Pharmaceutical Group
  26. 8.5.1 Harbin Pharmaceutical Group Company Information
  27. 8.5.2 Harbin Pharmaceutical Group Business Overview
  28. 8.5.3 Harbin Pharmaceutical Group Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Harbin Pharmaceutical Group Traditional Chinese Herbal Medicine Product Portfolio
  30. 8.5.5 Harbin Pharmaceutical Group Recent Developments
  31. 8.6 Guangzhou Pharmaceutical
  32. 8.6.1 Guangzhou Pharmaceutical Company Information
  33. 8.6.2 Guangzhou Pharmaceutical Business Overview
  34. 8.6.3 Guangzhou Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  36. 8.6.5 Guangzhou Pharmaceutical Recent Developments
  37. 8.7 Wuzhou Pharmaceutical
  38. 8.7.1 Wuzhou Pharmaceutical Company Information
  39. 8.7.2 Wuzhou Pharmaceutical Business Overview
  40. 8.7.3 Wuzhou Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wuzhou Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  42. 8.7.5 Wuzhou Pharmaceutical Recent Developments
  43. 8.8 ZBD Pharmaceutical
  44. 8.8.1 ZBD Pharmaceutical Company Information
  45. 8.8.2 ZBD Pharmaceutical Business Overview
  46. 8.8.3 ZBD Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ZBD Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  48. 8.8.5 ZBD Pharmaceutical Recent Developments
  49. 8.9 Yusheng Pharmaceutical
  50. 8.9.1 Yusheng Pharmaceutical Company Information
  51. 8.9.2 Yusheng Pharmaceutical Business Overview
  52. 8.9.3 Yusheng Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Yusheng Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  54. 8.9.5 Yusheng Pharmaceutical Recent Developments
  55. 8.10 Tongrentang
  56. 8.10.1 Tongrentang Company Information
  57. 8.10.2 Tongrentang Business Overview
  58. 8.10.3 Tongrentang Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tongrentang Traditional Chinese Herbal Medicine Product Portfolio
  60. 8.10.5 Tongrentang Recent Developments
  61. 8.11 TASLY
  62. 8.11.1 TASLY Company Information
  63. 8.11.2 TASLY Business Overview
  64. 8.11.3 TASLY Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TASLY Traditional Chinese Herbal Medicine Product Portfolio
  66. 8.11.5 TASLY Recent Developments
  67. 8.12 Shineway Pharmaceutical
  68. 8.12.1 Shineway Pharmaceutical Company Information
  69. 8.12.2 Shineway Pharmaceutical Business Overview
  70. 8.12.3 Shineway Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shineway Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  72. 8.12.5 Shineway Pharmaceutical Recent Developments
  73. 8.13 Livzon
  74. 8.13.1 Livzon Company Information
  75. 8.13.2 Livzon Business Overview
  76. 8.13.3 Livzon Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Livzon Traditional Chinese Herbal Medicine Product Portfolio
  78. 8.13.5 Livzon Recent Developments
  79. 8.14 Jumpcan
  80. 8.14.1 Jumpcan Company Information
  81. 8.14.2 Jumpcan Business Overview
  82. 8.14.3 Jumpcan Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jumpcan Traditional Chinese Herbal Medicine Product Portfolio
  84. 8.14.5 Jumpcan Recent Developments
  85. 8.15 Green Valley Pharma
  86. 8.15.1 Green Valley Pharma Company Information
  87. 8.15.2 Green Valley Pharma Business Overview
  88. 8.15.3 Green Valley Pharma Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Green Valley Pharma Traditional Chinese Herbal Medicine Product Portfolio
  90. 8.15.5 Green Valley Pharma Recent Developments
  91. 8.16 Gerun Pharmaceutical
  92. 8.16.1 Gerun Pharmaceutical Company Information
  93. 8.16.2 Gerun Pharmaceutical Business Overview
  94. 8.16.3 Gerun Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Gerun Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  96. 8.16.5 Gerun Pharmaceutical Recent Developments
  97. 8.17 Fusen Pharmaceutical
  98. 8.17.1 Fusen Pharmaceutical Company Information
  99. 8.17.2 Fusen Pharmaceutical Business Overview
  100. 8.17.3 Fusen Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Fusen Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  102. 8.17.5 Fusen Pharmaceutical Recent Developments
  103. 8.18 CR SANJIU
  104. 8.18.1 CR SANJIU Company Information
  105. 8.18.2 CR SANJIU Business Overview
  106. 8.18.3 CR SANJIU Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CR SANJIU Traditional Chinese Herbal Medicine Product Portfolio
  108. 8.18.5 CR SANJIU Recent Developments
  109. 8.19 China TCM
  110. 8.19.1 China TCM Company Information
  111. 8.19.2 China TCM Business Overview
  112. 8.19.3 China TCM Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  113. 8.19.4 China TCM Traditional Chinese Herbal Medicine Product Portfolio
  114. 8.19.5 China TCM Recent Developments
  115. 8.20 Chase Sun Pharmaceutical
  116. 8.20.1 Chase Sun Pharmaceutical Company Information
  117. 8.20.2 Chase Sun Pharmaceutical Business Overview
  118. 8.20.3 Chase Sun Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Chase Sun Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  120. 8.20.5 Chase Sun Pharmaceutical Recent Developments
  121. 8.21 Buchang Pharmaceutical
  122. 8.21.1 Buchang Pharmaceutical Company Information
  123. 8.21.2 Buchang Pharmaceutical Business Overview
  124. 8.21.3 Buchang Pharmaceutical Traditional Chinese Herbal Medicine Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Buchang Pharmaceutical Traditional Chinese Herbal Medicine Product Portfolio
  126. 8.21.5 Buchang Pharmaceutical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst